伊朗131I放射性药物生产工人的体内暴露监测。

Internal exposure monitoring of 131I-radiopharmaceutical production workers in Iran.

作者信息

Alirezazadeh N, Garshasbi H, Karimi Diba J

机构信息

National Radiation Protection Department, Iranian Nuclear Regulatory Authority, PO Box 14155-4494, Tehran, Iran.

出版信息

Radiat Prot Dosimetry. 2003;104(2):173-6. doi: 10.1093/oxfordjournals.rpd.a006178.

DOI:10.1093/oxfordjournals.rpd.a006178

PMID:12918795

Abstract

The programme and results of internal exposure monitoring of four individuals who have worked for 7 to 10 years in a 131I radiopharmaceutical production laboratory are described. The monitoring has been carried out using an in vivo thyroid measurement technique. The maximum and minimum average annual intakes of 131I received by the laboratory workers was 536 and 79 kBq, respectively. The highest estimated annual intake of 131I, incurred by one of the workers in a single year, was nearly 3.8 MBq. The mean values of the annual intakes by all the workers in their working periods in the laboratory was below the intake limits recommended by the ICRP.

摘要

描述了在131I放射性药物生产实验室工作7至10年的4名人员的体内暴露监测方案和结果。监测采用体内甲状腺测量技术进行。实验室工作人员接收的131I的最大和最小年平均摄入量分别为536和79 kBq。其中一名工作人员在单一年份中产生的131I的最高估计年摄入量接近3.8 MBq。所有工作人员在实验室工作期间的年摄入量平均值低于国际放射防护委员会（ICRP）建议的摄入限值。